Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Prone Positioning Combined With High-Flow Nasal Cannula Versus High-Flow Nasal Cannula in COVID-19 Induced Moderate to Severe ARDS

NCT04325906 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT04325906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04325906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Prone Positioning Combined With High-Flow Nasal Cannula Versus High-Flow Nasal Cannula in COVID-19 Induced Moderate to Severe ARDS
Lead sponsor
Rush University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
April 2, 2020
Completion date
February 21, 2021
Enrollment
224 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, corona virus infection, high flow nasal cannula, prone positioning